Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 17 » Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report
Please verify you are not a robot.